Supernus Pharmaceuticals reported $72.03M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Ani Pharmaceuticals ANIP:US $ 17.18M 1.64M
Aphria Inc APH:CN C$ 74.04M 19.84M
Aurora Cannabis Inc ACB:CN 48.61M 210K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Canopy Growth Corp WEED:CN C$ 141.71M 30.66M
Cara Therapeutics CARA:US $ 5.88M 262K
Corcept Therapeutics CORT:US $ 30.53M 504K
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Horizon Pharma HZNP:US 360.26M 5.06M
JAZZ PHA JAZZ:US 363.68M 65.35M
Lannett LCI:US $ 18.9M 2.67M
Marinus Pharmaceuticals MRNS:US 9.45M 2.62M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Pfizer PFE:US $ 2.73B 61M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Supernus Pharmaceuticals SUPN:US $ 72.03M 2.5M
Teva Pharmaceutical Industries TEVA:US 864M 32M
United Therapeutics UTHR:US $ 109.1M 3.7M
Xeris Pharmaceuticals Inc XERS:US $ 24.24M 1.69M